Antibacterial and Antifungal Activities of the Leaf Exudate of Aloe megalacantha Baker
Table 1
Zone of inhibition of the leaf exudate of Aloe megalacantha against bacterial species.
Bacterial strains
Diameter of zone of inhibition in mm
Latex (mg/mL)
Ceftriaxone 30 µg
DMSO
200
100
50
S. aureus ATCC 29213 (standard)
16.63 ± 0.12a2b1c2
14.23 ± 0.53a2c2
11.5 ± 0.16a2
22.34 ± 0.734 0
S. aureus (clinical isolate)
15.67 ± 0.26a3b2c1
12.46 ± 0.29a3c3
10.98 ± 0.3a2
14.11 ± 0.61
0
E. coli ATCC 25922 (standard)
15.45 ± 0.23a2b2c2
11.36 ± 0.71a2c3
9.66 ± 0.91a2
24 ± 0.28
0
E. coli (clinical isolate)
14.48 ± 0.28a2b1c2
10.8 ± 0.32a2c3
9.53 ± 0.32a2
0.00 ± 0.00
0
P. aeruginosa ATCC 27853 (standard)
15.66 ± 0.04a2b2c2
12.43 ± 0.6a2c2
9.57 ± 0.74a2
27.03 ± 0.31
0
K. pneumonia ATCC 700603 (standard)
15.00 ± 0.12a2b2c2
11.6 ± 0.61a2c3
10 ± 0.21a2
22.8 ± 0.27
0
Values are expressed as mean ± SEM (n = 3), and analysis was carried out with one-way ANOVA followed by the Tukey test; acompared to the positive control, bto 100 mg/mL, and cto 50 mg/mL, ,, and . 0 = negative control has shown no antibacterial activity; ceftazidime 30 µg.